EGCG inhibition of NF-κB also promotes the inhibition of aberrant NO production characterized in neuroinflammation, as evidenced in the downregulation of NOS1 (which is implicated in vascular inflammation and is connected to the NF-kB pathway). Here, NOS1 is linked to inflammatory response.